Valuation: MaaT Pharma

Market Cap 19.41M 21.85M 18.15M 16.54M 31.14M 2.1B 31.57M 220M 85M 1.07B 82.04M 80.26M 3.44B P/E 2026 *
-0.54x
P/E 2027 * -0.93x
Enterprise Value 33.21M 37.39M 31.06M 28.3M 53.29M 3.6B 54.02M 376M 145M 1.83B 140M 137M 5.89B EV / Sales 2026 *
3.41x
EV / Sales 2027 * 1.81x
Free-Float
36.85%
Yield 2026 *
-
Yield 2027 * -
1 day-2.14%
1 week-11.11%
Current month-7.01%
1 month-65.95%
3 months-61.82%
6 months-82.38%
Current year-79.04%
1 week 1
Extreme 1
1.28
1 month 1
Extreme 1
3.04
Current year 1
Extreme 1
8.62
1 year 1
Extreme 1
8.62
3 years 1
Extreme 1
9.96
5 years 1
Extreme 1
14.4
10 years 1
Extreme 1
14.4
Manager TitleAgeSince
Chief Executive Officer - 2013-12-31
Director of Finance/CFO 59 2024-10-31
Chief Tech/Sci/R&D Officer - 2024-06-23
Director TitleAgeSince
Director/Board Member - 2013-12-31
Director/Board Member 57 2013-12-31
Chairman - 2015-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
5/28/26 Buy

Founder

2,000 0.0106%
1/29/26
Seventure Partners SA
SellCompany 25,423 0.1356%
1/28/26
Seventure Partners SA
SellCompany 57,964 0.3091%
Change 5-day change 1-year change 3-year change Capi.($)
-2.14%-11.11%-76.77%-79.51% 21.85M
+4.16%+3.04%+49.37%+94.17% 74.41B
-2.97%-3.38%+22.10%+74.86% 59.26B
+0.91%-0.11%+4.83%+35.22% 47.14B
-0.57%-3.82%+27.26%+34.13% 42.91B
+0.93%+1.12%+353.54%+692.01% 44.13B
-1.15%-1.82%+2.64%+98.47% 40.79B
+3.32%+3.49%+10.10%+51.23% 30.77B
-2.68%+2.92%+29.63%+22.72% 29.31B
-0.60%-8.59%-29.51%+324.57% 23.71B
Average -0.10%-2.31%+39.32%+134.79% 39.25B
Weighted average by Cap. +0.37%-0.32%+57.50%+150.49%

Financials

2026 *2027 *
Net sales 9.75M 10.98M 9.12M 8.31M 15.64M 1.06B 15.86M 110M 42.7M 538M 41.22M 40.32M 1.73B 28.88M 32.51M 27.01M 24.61M 46.33M 3.13B 46.97M 327M 126M 1.59B 122M 119M 5.12B
Net income -31.69M -35.68M -29.64M -27.01M -50.85M -3.44B -51.55M -359M -139M -1.75B -134M -131M -5.62B -15.31M -17.24M -14.32M -13.05M -24.56M -1.66B -24.9M -173M -67.05M -845M -64.72M -63.32M -2.71B
Net Debt 13.8M 15.54M 12.91M 11.76M 22.15M 1.5B 22.45M 156M 60.46M 762M 58.35M 57.09M 2.45B 32.85M 36.98M 30.72M 27.99M 52.7M 3.56B 53.43M 372M 144M 1.81B 139M 136M 5.82B
Logo MaaT Pharma
MaaT Pharma is a late-stage biotechnology company and a leader in the development of intestinal microbiota-based drugs designed to modulate the immune system of cancer patients and improve their survival. A pioneer in its field, MaaT Pharma is developing the first immunomodulatory drug candidate based on intestinal microbiota in oncology, currently in phase 3 clinical evaluation. Thanks to its proprietary pooling (combining donations of healthy microbiota) and microbial co-culture technologies, MaaT Pharma is developing standardised drugs with high bacterial diversity, aimed at improving the survival of cancer patients.
Employees
56
Date Price Change Volume
26-10-02 €1.008 -2.14% 123,749
26-10-01 €1.030 -4.98% 112,846
26-09-30 €1.084 -4.07% 92,618
26-09-29 €1.130 -0.88% 73,643
26-09-28 €1.140 +0.53% 156,328
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
1.030EUR
Average target price
6.500EUR
Spread / Average Target
+531.07%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MAAT Stock